期刊文献+

阿德福韦酯治疗前C和/或C区变异HBV感染近期疗效观察

暂未订购
导出
摘要 目的观察阿德福韦酯(ADV)治疗前C和/或C区变异的慢性乙型肝炎患者和无变异的HBeAg阳性慢性乙型肝炎患者1年期的疗效。方法选择36例前C和/或C区变异的HBeAg阴性慢性乙型肝炎患者和13例HBeAg阳性慢性乙型肝炎患者,给予ADV10mg,每日1次口服,疗程1年。结果接受ADV治疗1年后前C区变异组、C区变异组,前C/C区变异组和无变异HBeAg阳性组患者的ALT复常率分别为81.8%(9/11),84.6%(11/13),83.3%(10/12)和84.6%(11/13),各组之间无显著性差异(P>0.05);HBV DNA阴转率分别为34.4%(4/11),30.8%(4/13),25%(3/12)和38.4%(5/13),各组之间无显著性差异(P>0.05)。结论阿德福韦酯治疗前C和/或C区变异慢性乙型肝炎和无变异HBeAg阳性慢性乙型肝炎的1年期疗效相似。
出处 《实用肝脏病杂志》 CAS 2008年第1期43-44,共2页 Journal of Practical Hepatology
  • 相关文献

参考文献6

二级参考文献38

  • 1Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001, 34:1225-1241
  • 2Bock CT, Tillmann H, Torresi J, et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology. 2002, 122:264-273.
  • 3Stuyver LJ, Locarnini SA, Lok A, et al. Nomenclature for antiviralresistant human hepatitis B virus mutations in the polymerase region.Hepatology 2001, 33 : 751-757.
  • 4Torresi J, Earnest-Silveira L, Deliyarmis G, et al. Reduced antigeriicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology, 2002, 293:305-313.
  • 5Angus P, Vaughan R, Xiong S, et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology. 2003, 125:292-297.
  • 6Bozdayi AM, Uzunalimoglu O, Turkyilmaz AR, et al. YSDD: a novel mutation in HBV DNA polyrnerase confers clinical resistance to lamivudine. J Viral Hepatitis. 2003, 10:256-265.
  • 7PERRILLO R, SCHIFF E, YOSHIDA E, et al. Adefovir dipivolxil for the treatment of lamivudine-resistant hepatitis B mutants[J]. Hepatology, 2000, 32 (1): 129-134.
  • 8LAI CL, CHIEN RN, LEUNG NWY, et al. A one year trail of lamivudine for chronic hepatitis B[J]. N Engl J Med, 1998, 339(2) :61-68.
  • 9LAU DT, KHOKHAR F, DOO E, et al. Long-Term therapy of chronic hepatitis B with lamivudine [J]. Hepatology, 2000, 32(4):828-834.
  • 10BOCK CT, TILLMANN HL, TORRESI J. Selection of hepatitis B vires polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation [J]. Gastroenterology,2002, 122(2) :264-273.

共引文献320

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部